BTIG Reiterates Buy on LifeMD, Maintains $10 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 87.2%

Neg 0% Neu 87.2% Pos 0%

BTIG analyst David Larsen reiterates LifeMD (NASDAQ:LFMD) with a Buy and maintains $10 price target.

Comments

No comments yet. Be the first!